Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Sonia M. Davis, PhD
JCP
Original Research
Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia
September 21, 2010
Somaia Mohamed
,
Robert A. Rosenheck
,
Joseph P. McEvoy
, et al
JCP
Original Research
Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
August 10, 2010
T. Scott Stroup
,
Robert A. Rosenheck
,
Richard S. E. Keefe
, et al
JCP
Original Research
The Treatment of Chronic Depression, Part 2: A Double-Blind, Randomized Trial of Sertraline and Imipramine
November 15, 1998
Susan G. Kornstein
,
Michael E. Thase
,
Robert M. A. Hirschfeld
, et al
JCP
Original Research
The Treatment of Chronic Depression, Part 3: Psychosocial Functioning Before and After Treatment With Sertraline or Imipramine
November 15, 1998
Susan G. Kornstein
,
Alan F. Schatzberg
,
Michael E. Thase
, et al
